​

Coeptis Therapeutics (COEP) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Coeptis Therapeutics Revenue Highlights

Latest Revenue (Y)

$1.36M

Latest Revenue (Q)

$62.87K

Coeptis Therapeutics Revenue by Period

Coeptis Therapeutics Revenue by Year

DateRevenueChange
2025-12-31$1.36M100.00%
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31--100.00%
2021-12-31$75.00K143.82%
2020-12-31$30.76K100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2005-12-31-100.00%
2004-12-31--

Coeptis Therapeutics generated $1.36M in revenue during NA 2025, up 100.00% compared to the previous quarter, and up 4431.08% compared to the same period a year ago.

Coeptis Therapeutics Revenue by Quarter

DateRevenueChange
2025-03-31$62.87K-96.63%
2024-12-31$1.86M100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$1.50M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31--100.00%
2021-09-30$9.89K100.00%
2021-06-30--100.00%
2021-03-31$75.00K100.00%
2020-11-30-100.00%
2020-08-31-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2005-12-31-100.00%
2005-09-30-100.00%
2005-06-30-100.00%
2005-03-31-100.00%
2004-12-31-100.00%
2004-09-30--

Coeptis Therapeutics generated $62.87K in revenue during Q1 2025, up -96.63% compared to the previous quarter, and up 4.19% compared to the same period a year ago.

Coeptis Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
OTLKOutlook Therapeutics$1.41T$-1.21M
KPTIKaryopharm Therapeutics$146.07M$44.04M
IPSCCentury Therapeutics$109.16M-
CUECue Biopharma$27.47M$2.95M
COEPCoeptis Therapeutics$1.36M$62.87K
NRXPNRx Pharmaceuticals$1.23M$242.00K
EQEquillium$130.00K-
SNTISenti Biosciences$22.00K-
OSTXOS Therapies--
MDCXMedicus Pharma--
TELOTelomir Pharmaceuticals--

COEP Revenue FAQ

What is Coeptis Therapeutics’s yearly revenue?

Coeptis Therapeutics's yearly revenue for 2025 was $1.36M, representing an increase of 100.00% compared to 2024. The company's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. COEP's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022.

What is Coeptis Therapeutics’s quarterly revenue?

Coeptis Therapeutics's quarterly revenue for Q1 2025 was $62.87K, a -96.63% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $1.86M, a 100.00% increase from the previous quarter (Q3 2024), and a 24.08% increase year-over-year (Q4 2023). COEP's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023).

What is Coeptis Therapeutics’s revenue growth rate?

Coeptis Therapeutics's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was 1717.39%.